Treatment with CT-996 reduced placebo-adjusted mean body weight by 6.1% within four weeks in participants who were obese but did not have type 2 diabetes.
CT-996 shows remarkable effect on weight loss in patients with obesity and type 2 diabetes
Leave a comment
